With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

The RNAi Technology Market offers growth opportunities in drug development, gene therapy, and agriculture due to RNAi's precision in gene silencing. Key drivers include the rising demand for RNAi ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and disease resistance.

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

By uncovering RNA’s previously unknown function to repair DNA damage, our findings show how RNA may directly contribute to the stability and evolution of the genome. It’s not merely a passive ...